Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety and Efficacy of Nifedipine/Candesartan FDC in Hypertension
NCT01788358Phase 3Completed
- Sponsor
- Bayer
- Start
- Feb 2013
- Primary completion
- May 2014
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of nifedipine GITS, candesartan cilexetil in essential hypertension, sponsored by Bayer. Started Feb 2013; status: completed.
02
Drugs
nifedipine GITScandesartan cilexetil
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01788358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01788358.